Related by context. All words. (Click for frequent words.) 71 leading oral taxane 68 sapacitabine 68 alvespimycin 67 INCB# [001] 67 MDV# 67 AP# [003] 67 ganetespib 67 MGCD# [001] 66 Azedra 66 phase IIb clinical 66 relapsed multiple myeloma 66 FOLOTYN 66 ixabepilone 66 BAY #-# 65 metaglidasen 65 Archexin 65 belinostat 65 eniluracil 65 romidepsin 65 OvaRex ® MAb 65 Asentar 65 AQ4N 65 valopicitabine 65 obatoclax 65 forodesine 65 Tesetaxel 65 Zolinza 64 OXi# 64 hormone refractory prostate cancer 64 deforolimus 64 Symadex 64 INCB# [002] 64 PI3K/Akt pathway inhibitor 64 tamibarotene 64 pralatrexate 64 YONDELIS 64 blinatumomab 64 TRISENOX 64 PXD# 64 methylnaltrexone 64 Ophena TM 64 Zerenex 63 Annamycin 63 Troxatyl 63 Ceflatonin 63 oral taxane 63 CoFactor 63 PSMA ADC 63 oral deforolimus 63 tanespimycin 63 PEG SN# 63 AEG# 63 PEG Interferon lambda 63 SNT MC# 63 talactoferrin 63 Proxinium TM 63 Aplidin 63 elotuzumab 63 GRN#L 63 torezolid phosphate 63 RDEA# 63 voreloxin 63 IMiDs 63 Nanobody 63 HGS ETR1 63 OncoVEX GM CSF 63 radiation sensitizer 63 novel VDA molecule 63 Panzem R 63 registrational 63 JAK inhibitors 63 CBLC# 63 MAGE A3 ASCI 63 custirsen 63 HuMax CD4 63 orally administered inhibitor 62 oral ridaforolimus 62 tesmilifene 62 Exherin TM 62 ELACYT 62 Amplimexon 62 MEK inhibitors 62 hematological malignancies 62 axitinib 62 HGS# 62 Xanafide 62 bafetinib 62 Panzem R NCD 62 Vandetanib 62 PrevOnco ™ 62 Tamibarotene 62 perifosine 62 docetaxel Taxotere R 62 Nexavar ® 62 tezampanel NGX# 62 XmAb# 62 ulimorelin 62 Bicifadine 62 vosaroxin 62 Chemophase 62 vidofludimus 62 HGS ETR1 mapatumumab 62 PNP inhibitor 62 Amrubicin 62 Ceflatonin R 62 Rebif ® 62 antithrombotic 62 HuLuc# 62 Proellex TM 62 Marqibo 62 HCV protease inhibitor 62 JAK1 62 Atiprimod 62 Aflibercept 61 L BLP# 61 BRIM2 61 oral prodrug 61 Omacetaxine 61 MOZOBIL 61 IAP inhibitors 61 IMGN# 61 Cloretazine 61 sorafenib tablets 61 EOquin 61 XL# [003] 61 picoplatin 61 EFAPROXYN 61 LHRH antagonist 61 Neuradiab 61 anticancer agent 61 daclizumab 61 Evoltra ® 61 Onco TCS 61 Rezular 61 TBC# 61 Lenocta 61 REOLYSIN ® 61 vorinostat 61 Allovectin 7 61 epothilone 61 IAP inhibitor 61 KNS # 61 eltrombopag 61 Glufosfamide 61 OMP #M# 61 Phase 2b clinical 61 ISTODAX 61 T DM1 61 Virulizin ® 61 phase IIb 61 forodesine hydrochloride 61 tezampanel 61 Cloretazine R VNP#M 61 darapladib 61 Dacogen injection 61 TYKERB 61 HER2 positive metastatic breast 61 R#/MEM # 61 cutaneous T cell 61 PEG PAL 61 diabetic neuropathic pain 61 Golimumab 61 mapatumumab 61 carfilzomib 61 Phenoptin 61 apremilast 61 OHR/AVR# 61 Aurexis 61 EOquin TM 61 Azedra TM 61 CA4P 61 Indibulin 61 Traficet EN 61 enzastaurin 61 MNTX 61 TYZEKA 61 PrevOnco 61 Phase Ib 61 TREANDA 61 HGS ETR2 61 IMC #B 61 Alocrest 61 lesinurad 61 HRPC 61 trastuzumab DM1 T DM1 61 Fibrillex TM 61 ATL# [001] 61 Cetrorelix 61 alvimopan 61 IRX 2 61 relapsed refractory multiple myeloma 61 Phase #/#a trial 61 metastatic renal cell 61 celgosivir 61 Gabapentin GR 61 pertuzumab 61 NP2 Enkephalin 60 seliciclib CYC# 60 thymalfasin 60 zanolimumab 60 ospemifene 60 investigational monoclonal antibody 60 TAFA# 60 IMC A# 60 ruxolitinib 60 lomitapide 60 oxypurinol 60 CYT# potent vascular disrupting 60 Genasense 60 AZX# 60 ICA # 60 TELCYTA 60 Dapagliflozin 60 albinterferon alfa 2b 60 apaziquone 60 NXL# 60 telomerase therapeutic 60 lumiliximab 60 oral anticancer 60 Ketotransdel 60 vascular disrupting agent 60 PSN# [002] 60 mertansine 60 bendamustine 60 Phase Ib study 60 novel anticancer 60 Allovectin 7 ® 60 tramiprosate Alzhemed TM 60 ozarelix 60 budesonide foam 60 sorafenib Nexavar ® 60 ThermoDox R 60 farletuzumab 60 BENLYSTA ® 60 Vicinium TM 60 ridaforolimus 60 AzaSite Plus 60 relapsed MM 60 drug ISA# 60 APEX PD 60 GAP #B# 60 Androxal TM 60 regorafenib 60 entinostat 60 ADVEXIN 60 multi kinase inhibitor 60 AZILECT ® 60 metastatic CRC 60 SERMs 60 rNAPc2 60 phase IIa clinical 60 docetaxel Taxotere ® 60 EP #R 60 MEK inhibitor RDEA# 60 ELND# 60 HuMax EGFr 60 CR# vcMMAE 60 Phase #b/#a clinical 60 DAVANAT R 60 Pazopanib 60 HspE7 60 selective androgen receptor modulator 60 anticancer therapy 60 YONDELIS R 60 DAVANAT 60 anticancer compound 60 sodium thiosulfate STS 60 cilengitide 60 FOLOTYN ® 60 registrational trial 60 PROMACTA 60 tivozanib 60 EndoTAG TM -1 60 ceftaroline 60 APOPTONE 60 HuMax CD# 60 Azixa 60 adecatumumab 60 clofarabine 60 Insegia 60 EndoTAG 60 BENLYSTA 60 TACI Ig 60 velafermin 60 sunitinib malate 60 MYDICAR ® 60 Neulasta ® 60 metastatic hormone refractory 60 investigational compounds 60 Amigal 60 Phase IIb clinical trials 60 Homspera 60 Jevtana 60 mRCC 60 AEGR 60 glufosfamide 60 refractory gout 60 Mipomersen 60 BEMA Buprenorphine 60 Tekamlo 60 PDE4 inhibitor 60 atacicept 60 Plenaxis TM 60 ZADAXIN 60 Targretin 60 Phase Ib II 60 ONCONASE R 60 ASA# 60 Tyrima 60 Actemra tocilizumab 60 Voreloxin 60 OvaRex R 60 therapeutic monoclonal antibodies 60 therapeutic monoclonal antibody 59 CEQ# 59 BrachySil 59 Fodosine 59 S/GSK# 59 Solazed 59 veltuzumab 59 dose cohort 59 vandetanib 59 ularitide 59 TG# [003] 59 DP b# 59 Viprinex 59 Icatibant 59 Perifosine 59 VEGF Trap 59 OncoVEX 59 Clevudine 59 taxane 59 solid tumors 59 MGd 59 castrate resistant prostate cancer 59 calcineurin inhibitors 59 NVA# 59 Celator 59 PRT# 59 BiTE antibody 59 CCR9 antagonist 59 lenalidomide Revlimid R 59 Talabostat 59 Phase III clinical 59 Cleviprex TM clevidipine 59 carcinoma HCC 59 trastuzumab DM1 59 Erbitux cetuximab 59 Sym# 59 Targretin capsules 59 dacetuzumab 59 drug GAP #B# 59 dexpramipexole 59 Zalbin 59 Stedivaze 59 proteasome inhibitor 59 Ceflatonin ® 59 tocilizumab 59 receptor tyrosine kinase inhibitor 59 pivotal Phase III 59 ONTAK 59 Myocet 59 AMR# 59 NGX# 59 PLK1 SNALP 59 gemcitabine Gemzar ® 59 SUPPRELIN R LA 59 Onconase 59 eculizumab 59 Abiraterone acetate 59 evaluating tivozanib 59 CTAP# Capsules 59 relapsing remitting multiple sclerosis 59 HCD# [002] 59 vascular disrupting agents 59 PRTX 59 lintuzumab 59 NUVIGIL 59 chemotherapeutic drug 59 IMP# 59 corticosteroid dexamethasone 59 TRIOLEX 59 BrachySil TM 59 immunotherapeutic agent 59 MKC# MKC# PP 59 Nanobody ® 59 Virulizin R 59 metastatic castration resistant 59 Toraymyxin TM 59 StemEx 59 Bezielle 59 Nexavar sorafenib 59 Restanza 59 nucleoside analog 59 phase Ib 59 Pemetrexed 59 IMA# 59 Clolar ® 59 TOCOSOL Paclitaxel 59 immunomodulatory 59 Chrysalin 59 Actimmune ® 59 Desmoteplase 59 JANUVIA 59 DU #b 59 Cloretazine ® 59 oral methylnaltrexone 59 L Annamycin 59 BCX# 59 Behcet uveitis 59 acyclovir Lauriad R 59 ambrisentan 59 ORENCIA R 59 THALOMID 59 UPLYSO 59 perifosine KRX 59 panitumumab 59 tiapamil 59 Civacir 59 Phase #b/#a 59 assessing T DM1 59 safinamide 59 GALNS 59 histone deacetylase HDAC inhibitor 59 JAK inhibitor 59 Soliris TM eculizumab 59 riociguat 59 AzaSite Xtra 59 liposomal formulation 59 RhuDex ® 59 delafloxacin 59 including eniluracil ADH 59 Prestara 59 pomalidomide 59 TELINTRA 59 chemopreventive agent 59 dirucotide 59 hematologic malignancies 59 immunomodulator 59 AeroLEF 59 MKC# MT 59 Urocidin 59 TKM ApoB 59 Saxagliptin 59 cediranib 59 MEK inhibitor 59 tranilast 59 Bortezomib 59 Gemzar ® 59 oral picoplatin 59 PREZISTA r 59 systemic ALCL 59 vemurafenib 59 abiraterone acetate 59 otelixizumab 59 metastatic castrate resistant 59 Azilect ® 59 cell lymphoma CTCL 59 AZILECT R 59 platinum refractory 59 bardoxolone 59 bicifadine 59 RSD# oral 59 virus HCV protease inhibitor 59 dose cohorts 59 pexiganan 59 anti amnesic 59 lupus nephritis 59 direct renin inhibitor 58 Rasagiline 58 HepeX B 58 Veronate 58 SCH # 58 rasagiline tablets 58 metastatic sarcomas 58 ProSavin 58 initiate Phase 1b 58 SLx 58 AGGRASTAT ® 58 RGB # 58 myelofibrosis 58 Laquinimod 58 urocortin 2 58 Synavive 58 oral salmon calcitonin 58 sodium Injection 58 ofatumumab 58 leukemia AML 58 metastatic colorectal 58 anticancer agents 58 CYT# 58 amrubicin 58 demonstrated antitumor activity 58 trabectedin 58 generation Hsp# inhibitor 58 sorafenib Nexavar 58 IV Busulfex 58 CD# antibody [001] 58 bazedoxifene 58 aflibercept 58 Phase IIb clinical 58 Aviptadil 58 phase III isavuconazole 58 huN# DM1 58 severe hypercholesterolemia 58 bexarotene 58 FTY# 58 Phase 1b 58 SinuNase 58 gefitinib Iressa 58 Elagolix 58 Phase IIIb clinical 58 anti fibrotic 58 kidney urologic 58 vinorelbine 58 hepatocellular cancer 58 SAR# [004] 58 RAPTIVA 58 LymphoStat B belimumab 58 oritavancin 58 ISIS # 58 Menerba 58 AeroLEF TM 58 angiogenesis inhibitor 58 aflibercept VEGF Trap 58 alkylating agent 58 ponatinib 58 Phase #b/#a trial 58 indolent NHL 58 Telavancin 58 elagolix 58 Genasense ® 58 cangrelor 58 fidaxomicin 58 huC# DM4 58 pan HDAC inhibitor 58 SCCHN 58 VIDAZA 58 bendamustine HCl 58 imetelstat 58 Aplidin R 58 UVIDEM 58 Phase 2b trial 58 Apoptone 58 phase IIb trial 58 erlotinib Tarceva 58 omecamtiv mecarbil 58 ATL/TV# 58 Genasense R oblimersen 58 ASONEP 58 synthetic retinoid 58 Ixempra 58 Panzem 58 Taxotere docetaxel 58 ACZ# 58 apoptosis inducer 58 Phase 2a trial 58 pegfilgrastim 58 Taxotere R 58 GW# [003] 58 Phase IIa trials 58 Zerenex ™ 58 Zavesca R 58 B CLL 58 Genasense ® oblimersen 58 SIMPONI 58 SUCCEED trial 58 DACH platinum 58 azacitidine 58 Æterna Zentaris 58 DOS# 58 dexanabinol 58 KRN# 58 radezolid 58 PhosLo 58 preclinically 58 tramiprosate 58 Elesclomol 58 CD# monoclonal antibody 58 integrase inhibitor 58 mitogen activated ERK kinase 58 Imprime PGG 58 pharmacokinetic PK study 58 advanced metastatic prostate 58 Tavocept 58 INCB# [003] 58 Viramidine 58 GLP toxicology studies 58 ALN TTR# 58 PROSTVAC TM 58 Serdaxin 58 XL# anticancer compounds 58 CD3 monoclonal antibody 58 XmAb ® 58 cMET 58 omacetaxine 58 reslizumab 58 Cethrin 58 Actemra 58 balsalazide tablet 58 nucleoside analogue 58 NEUMUNE 58 ThermoDox 58 monotherapy 58 microtubule inhibitor 58 xenograft models 58 oral fludarabine 58 Prostate AdenoCarcinoma Treatment 58 renin inhibitor 58 generation antisense 58 tasocitinib 58 Bayer HealthCare Onyx Pharmaceuticals 58 chemotherapy induced neutropenia 58 Zybrestat 58 ISENTRESS 58 delta opioid receptor 58 dextofisopam 58 R sorafenib tablets 58 QNEXA 58 double blinded placebo 58 ZADAXIN ® 58 hepatitis C HCV 58 nab paclitaxel 58 CBLB# 58 MAXY alpha 58 ZYBRESTAT 58 bortezomib Velcade 58 monoclonal antibody therapies 58 radiotherapeutic 58 tafamidis 58 DDP# 58 arimoclomol 58 PD LID 58 CGEN # 58 Tarvacin TM 58 Phase IIB 58 Catena ® 58 recurrent glioblastoma multiforme 58 galiximab 58 Hsp# inhibitor 58 unique alkylating agent 58 Guanilib 58 cancer immunotherapies 58 investigational compound 58 anti EGFR antibody 58 Romidepsin 58 Uricase PEG 58 PANVAC VF 58 opioid induced bowel dysfunction 58 dosing cohort 58 Zytiga 58 CORT # 58 Loramyc R 58 palifosfamide 58 oral gallium 58 diarrhea predominant irritable 58 HMG CoA reductase inhibitors 58 betrixaban 58 temsirolimus 58 elvucitabine 58 GATTEX ® 58 #ME# 58 hypoxia activated prodrug 58 Dasatinib 57 Sebivo 57 RG# [001] 57 ofatumumab HuMax CD# 57 CIMZIA TM 57 Triolex 57 midstage clinical 57 vilazodone 57 siRNA therapeutics 57 CYC# 57 castration resistant prostate cancer 57 ALN RSV# 57 compound INCB# 57 Avastin bevacizumab 57 R#/MEM 57 Sulonex TM 57 IV APAP 57 herpetic keratitis 57 ALN PCS 57 Nimotuzumab 57 lapatinib Tykerb 57 cutaneous T 57 OMNARIS HFA 57 Stimuvax R 57 histone deacetylase inhibitor 57 trial evaluating PRX# 57 lymphoma CTCL 57 Onrigin 57 TRAIL receptor antibodies 57 metastatic colorectal cancer 57 ONCONASE 57 GRN# 57 relapsed leukemia 57 talabostat 57 luliconazole 57 anidulafungin 57 DPX Survivac 57 Solazed TM 57 BRAF inhibitor 57 trastuzumab Herceptin R 57 evaluating T DM1 57 elacytarabine 57 Hepatocellular Carcinoma HCC 57 rheumatoid arthritis psoriatic arthritis 57 recurrent glioblastoma 57 GV# [001] 57 muraglitazar 57 anticoagulant reversing agent 57 TORISEL 57 ABRAXANE 57 adipiplon 57 Torisel 57 Personalized Immunotherapy 57 Vidaza R 57 Vaprisol 57 ProLindac 57 Octreolin 57 ThermoDox ® 57 Silodosin 57 PRX # 57 phase 2a 57 ADVANCE PD 57 RLY# 57 posaconazole 57 investigational therapies 57 GTC recombinant human 57 PF # [001] 57 colorectal lung 57 OncoVex 57 nonclinical studies 57 neratinib 57 Orphan Drug designations 57 brentuximab vedotin SGN 57 BYETTA ® 57 FOLFOX regimen 57 Advexin 57 velaglucerase alfa 57 novel histone deacetylase 57 StemEx R 57 Motesanib 57 refractory multiple myeloma 57 Eltrombopag 57 DPP4 inhibitor 57 zalutumumab 57 GSK# [001] 57 Alzhemed TM 57 Lixivaptan 57 dirucotide MBP# 57 depsipeptide 57 bevacizumab Avastin 57 NKTR 57 BYDUREON 57 trastuzumab emtansine T DM1 57 Frova ® 57 refractory APL 57 advanced carcinoid 57 Roche PEGASYS R 57 SparVax TM 57 Plicera 57 Pivotal Phase III 57 dimebon 57 Zelrix 57 PREOS R 57 danoprevir 57 darinaparsin 57 Vectibix panitumumab 57 highly selective adenosine 57 ONCASPAR 57 Intravenous CP 57 perampanel 57 Evoltra 57 RoACTEMRA 57 terlipressin 57 Tasimelteon 57 Exelixis compounds 57 Cloretazine R 57 nucleoside analogs 57 Tykerb lapatinib 57 subcutaneous formulation 57 generation purine nucleoside 57 Curaxin CBLC# 57 Cotara 57 Aganocide 57 immunomodulating 57 nalbuphine ER 57 multicenter Phase II 57 teduglutide 57 laquinimod 57 cardio renal 57 ketolide antibiotic 57 motesanib 57 Canvaxin TM 57 uric acid lowering 57 heavily pretreated 57 indibulin 57 ENMD # 57 drug pipeline TAFA# 57 clevudine 57 OMNARIS Nasal Spray 57 DCVax R 57 teriflunomide 57 anti TNF alpha 57 ostarine 57 pivotal Phase 57 Reverset 57 HQK 57 DXL# 57 TREDAPTIVE 57 decitabine 57 Exelixis XL# 57 goserelin 57 ENMD 57 Increlex R 57 PHX# 57 crofelemer 57 satraplatin 57 targeted radiotherapeutic 57 Debio 57 antitumor activity 57 Nanobodies 57 Aurora kinase 57 immune modulatory 57 Anturol TM 57 Teplizumab 57 Fludara 57 BEXXAR 57 silodosin 57 rhIGFBP 3 57 aleglitazar 57 Helsinn Healthcare 57 SPRYCEL ® 57 pitavastatin 57 Letairis ambrisentan 57 investigational immunotherapy 57 Virulizin 57 LEUKINE 57 TOCOSOL Camptothecin 57 XL# XL# 57 Harbor BioSciences 57 LY# [003] 57 pancreatic prostate 57 dalbavancin 57 SRT# [003] 57 trastuzumab Herceptin 57 REMOXY ® 57 Zadaxin 57 dose escalation Phase 57 Xeloda capecitabine 57 formerly LymphoStat B 57 paclitaxel Taxol ® 57 TRC# 57 faropenem 57 LEP ETU 57 Cellegesic 57 RECOTHROM 57 Arikace 57 insulin sensitizers 57 ERBITUX 57 Revimmune 57 Tarceva TM 57 daptomycin 57 CORLUX CORT # 57 Fludara ® 57 Xinlay 57 Excellarate 57 androgen independent 57 Aloxi injection 57 Gleevec resistant 57 nonsmall cell lung cancer 57 oral dnaJP1 57 Reclast Aclasta 57 BEMA TM Fentanyl 57 LymphoStat B TM 57 REYATAZ R 57 LBH# 57 BZL# 57 Fx #A 57 Raptiva ® 57 Phase IIa trial 57 CLORETAZINE TM VNP#M 57 AAG geldanamycin analog 57 Lu AA# 57 inhibitor RG# 57 prGCD 57 docetaxel chemotherapy 57 albiglutide 57 acute leukemias 57 Herceptin trastuzumab 57 Taxotere ® 57 ZOLINZA 57 sodium glucose cotransporter 57 refractory Hodgkin lymphoma 57 lintuzumab SGN 57 immunotherapeutic vaccine 57 Campath ® 57 Targeted Chemotherapy 57 Phase 2a 57 CCX# 57 GSK # 57 olmesartan 57 nitric oxide donating 57 AGILECT R 57 alefacept 57 Arcalyst 57 Folotyn 57 nicotinic alpha 7 57 Dextofisopam 57 vinca alkaloid 57 anti angiogenic therapy 57 oral anticoagulant 57 mTOR inhibitors 57 Orazol 57 Sudhir Agrawal D.Phil 57 ancrod 57 Opexa 57 topical antifungal 57 CytoFab 57 TRO# 57 Oral NKTR 57 PLX# 57 Tarvacin 57 zileuton 57 Protectan CBLB# 57 signal transduction inhibitor 57 Epratuzumab 56 Relivar 56 aclidinium 56 molecular entities NMEs 56 RAPAFLO 56 thetreatment 56 TRISENOX ® 56 RSR# 56 epigenetic therapies 56 evaluating picoplatin 56 CYCLOSET 56 linaclotide 56 Dabigatran etexilate 56 PS# [001] 56 SUTENT 56 Onalta 56 Alvesco R 56 Revlimid lenalidomide 56 Belimumab 56 fostamatinib 56 cetuximab Erbitux 56 brivaracetam 56 Genz # 56 Entereg R 56 mycophenolate mofetil 56 Erlotinib 56 rALLy 56 Phase Ib clinical trials 56 BRIM3 56 nimotuzumab 56 GRNVAC1 56 Loramyc 56 AKT inhibitor 56 Velcade bortezomib 56 odanacatib 56 oncology indications 56 casopitant 56 refractory metastatic colorectal cancer 56 MYDICAR 56 pediatric acute lymphoblastic 56 Safinamide 56 Quinamed 56 Phase 1b trial 56 chemotherapeutics 56 cannabinor 56 idarubicin 56 Litx 56 multicenter Phase III 56 TKB# 56 ocular formulation 56 Hycamtin 56 Mylotarg 56 Daclizumab 56 ADXS# 56 Zingo TM 56 chronic HCV 56 placebo controlled Phase 56 2 methoxyestradiol 56 tyrosine kinase inhibitor 56 Genasense oblimersen sodium Injection 56 nilotinib 56 nitazoxanide 56 orBec R 56 recurrent NSCLC 56 Phase IIb trials 56 indacaterol 56 ANA# 56 bortezomib Velcade R 56 Raptiva R 56 olaparib 56 rALLy clinical trial 56 Shigamabs ®